Okun S, Lu D, Sew K, Subramaniam A, Lockwood W
Cancers (Basel). 2025; 17(2).
PMID: 39858062
PMC: 11764361.
DOI: 10.3390/cancers17020281.
Tomuleasa C, Tigu A, Munteanu R, Moldovan C, Kegyes D, Onaciu A
Signal Transduct Target Ther. 2024; 9(1):201.
PMID: 39138146
PMC: 11323831.
DOI: 10.1038/s41392-024-01899-w.
Nam D, Park S, Omole S, Um E, Hakami R, Hahn Y
PLoS One. 2024; 19(6):e0306345.
PMID: 38935609
PMC: 11210754.
DOI: 10.1371/journal.pone.0306345.
Crepaldi T, Gallo S, Comoglio P
Pharmaceuticals (Basel). 2024; 17(4).
PMID: 38675409
PMC: 11054789.
DOI: 10.3390/ph17040448.
Marrapodi R, Bellei B
Cancers (Basel). 2024; 16(5).
PMID: 38473275
PMC: 10930874.
DOI: 10.3390/cancers16050913.
Dysregulated Gab1 signalling in triple negative breast cancer.
Bongartz H, Mehwald N, Seiss E, Schumertl T, Nass N, Dittrich A
Cell Commun Signal. 2024; 22(1):161.
PMID: 38448989
PMC: 10916281.
DOI: 10.1186/s12964-024-01542-9.
Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma.
Astore S, Baciarello G, Cerbone L, Calabro F
Cancer Drug Resist. 2023; 6(3):517-546.
PMID: 37842234
PMC: 10571064.
DOI: 10.20517/cdr.2023.33.
Savolitinib: A Promising Targeting Agent for Cancer.
Lee T, Kim J, Lee M, Cho I, Paik W, Ryu J
Cancers (Basel). 2023; 15(19).
PMID: 37835402
PMC: 10571651.
DOI: 10.3390/cancers15194708.
Photodynamic reactions using high-intensity red LED promotes gingival wound healing by ROS induction.
Minagawa E, Yamauchi N, Taguchi Y, Umeda M
Sci Rep. 2023; 13(1):17081.
PMID: 37816801
PMC: 10564724.
DOI: 10.1038/s41598-023-43966-2.
The Role of GAB1 in Cancer.
Perez-Baena M, Cordero-Perez F, Perez-Losada J, Holgado-Madruga M
Cancers (Basel). 2023; 15(16).
PMID: 37627207
PMC: 10453317.
DOI: 10.3390/cancers15164179.
Conserved regulatory motifs in the juxtamembrane domain and kinase N-lobe revealed through deep mutational scanning of the MET receptor tyrosine kinase domain.
Estevam G, Linossi E, Macdonald C, Espinoza C, Michaud J, Coyote-Maestas W
bioRxiv. 2023; .
PMID: 37577651
PMC: 10418267.
DOI: 10.1101/2023.08.03.551866.
The Receptor Tyrosine Kinase c-Met Promotes Lipid Accumulation in 3T3-L1 Adipocytes.
Park Y, Jang B
Int J Mol Sci. 2023; 24(9).
PMID: 37175792
PMC: 10179087.
DOI: 10.3390/ijms24098086.
Epithelial Gab1 calibrates RIPK3-dependent necroptosis to prevent intestinal inflammation.
Xu J, Li S, Jin W, Zhou H, Zhong T, Cheng X
JCI Insight. 2023; 8(6).
PMID: 36795486
PMC: 10070107.
DOI: 10.1172/jci.insight.162701.
The hepatocyte growth factor/mesenchymal epithelial transition factor axis in high-risk pediatric solid tumors and the anti-tumor activity of targeted therapeutic agents.
Grundy M, Narendran A
Front Pediatr. 2022; 10:910268.
PMID: 36034555
PMC: 9399617.
DOI: 10.3389/fped.2022.910268.
Bacterial inhibition of Fas-mediated killing promotes neuroinvasion and persistence.
Maudet C, Kheloufi M, Levallois S, Gaillard J, Huang L, Gaultier C
Nature. 2022; 603(7903):900-906.
PMID: 35296858
DOI: 10.1038/s41586-022-04505-7.
KRAS and MET in non-small-cell lung cancer: two of the new kids on the 'drivers' block.
Garcia-Robledo J, Rosell R, Ruiz-Patino A, Sotelo C, Arrieta O, Zatarain-Barron L
Ther Adv Respir Dis. 2022; 16:17534666211066064.
PMID: 35098800
PMC: 8808025.
DOI: 10.1177/17534666211066064.
The Emerging Role of c-Met in Carcinogenesis and Clinical Implications as a Possible Therapeutic Target.
Faiella A, Riccardi F, Carteni G, Chiurazzi M, Onofrio L
J Oncol. 2022; 2022:5179182.
PMID: 35069735
PMC: 8776431.
DOI: 10.1155/2022/5179182.
Breast Cancer Antiestrogen Resistance 3 (BCAR3) promotes tumor growth and progression in triple-negative breast cancer.
Arras J, Thomas K, Myers P, Cross A, Osei A, Vazquez G
Am J Cancer Res. 2021; 11(10):4768-4787.
PMID: 34765292
PMC: 8569345.
HGF and MET: From Brain Development to Neurological Disorders.
Desole C, Gallo S, Vitacolonna A, Montarolo F, Bertolotto A, Vivien D
Front Cell Dev Biol. 2021; 9:683609.
PMID: 34179015
PMC: 8220160.
DOI: 10.3389/fcell.2021.683609.
Mesenchymal Epithelial Transition Factor Signaling in Pediatric Nervous System Tumors: Implications for Malignancy and Cancer Stem Cell Enrichment.
Khater A, Abou-Antoun T
Front Cell Dev Biol. 2021; 9:654103.
PMID: 34055785
PMC: 8155369.
DOI: 10.3389/fcell.2021.654103.